Abstract: This study aims to evaluate in vitro the release properties and biological behavior of original compositions of strontium (Sr)-loaded bone mineral cements. Strontium was introduced into vaterite CaCO 3 -dicalcium phosphate dihydrate cement via two routes: as SrCO 3 in the solid phase (SrS cements), and as SrCl 2 dissolved in the liquid phase (SrL cements), leading to different cement compositions after setting. Complementary analytical techniques implemented to thoroughly investigate the release/dissolution mechanism of Sr-loaded cements at pH 7.4 and 37 C during 3 weeks revealed a sustained release of Sr and a centripetal dissolution of the more soluble phase (vaterite) limited by a diffusion process. In all cases, the initial burst of the Ca and Sr release (highest for the SrL cements) that occurred over 48 h did not have a significant effect on the expression of bone markers (alkaline phosphatase, osteocalcin), the levels of which remained overexpressed after 15 days of culture with human osteoprogenitor (HOP) cells. At the same time, proliferation of HOP cells was significantly higher on SrS cements. Interestingly, this study shows that we can optimize the sustained release of Sr 2þ
INTRODUCTION
Trace elements, such as sodium, magnesium, strontium, and fluoride, are naturally found in human bone. 1, 2 They have attracted attention because previous studies have shown that they have an impact on bone mineral characteristics and on the biological activity of resorbable bone substitutes. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Research has particularly focused on the role played by strontium on bone formation and remineralization and it has led to therapies against bone degradation and especially against osteoporosis. 4, 5, 16 Strontium has been tested in different forms: carbonate, chloride, lactate, and ranelate. 4, 16 Strontium, already present in human plasma at concentrations of between 0.11 and 0.31 lmolÁL À1 , is a bone-seeking element (more than 99% of strontium is located in the bones). 3 Previous studies have shown that, at a low dose, strontium hinders osteoclast activity and favors the proliferation of osteoblast cells 3, 4, 11 ; therefore, on the one hand it acts synergistically against osseous resorption, while on the other hand it acts by increasing the number of sites of osseous formation. Other authors have reported the stimulating action of strontium on osseous collagen formation. 3, [8] [9] [10] [11] Nevertheless, it has been shown that at higher doses, strontium can have deleterious effects on bone mineralization: mineral density and calcium absorption are both reduced.
that even with high doses, less than 1 out of 10 Ca ions is substituted by Sr in the newly formed bone. 1 It seems that the local release of Sr from the bone substitute, directly into the osseous site, may be a solution for targeting a high turnover location while diminishing the administered strontium dose. Therefore, strontium has recently been introduced into hydroxyapatite-coatings, cements, dense or porous ceramics, and granulates. 12, 13, 15, [18] [19] [20] [21] [22] [23] [24] [25] Because of its higher atomic weight compared to calcium and phosphate, strontium has also recently been proposed and studied as an interesting contrast agent for increasing the radio-opacity of calcium phosphate ceramics. 21, 26 Calcium carbonate-calcium phosphate mixed cements have been presented as a promising resorbable and injectable material for bone reconstruction. 27, 28 The amount of strontium introduced into calcium-phosphate bone cement has to be optimized in order to provide both sufficient radio-opacity for the cement to be easily visualized and detected during minimally invasive surgery procedures and enough to favor bone formation without having deleterious effects on bone mineralization. However, to the best of our knowledge, no upper limit for the amount of strontium that should be incorporated into a bony defect has yet been defined.
In the present study, we investigated the introduction of strontium into a calcium carbonate-calcium phosphate cement through two different routes (Sr introduced as a mineral salt either in the solid phase or dissolved in the liquid phase) and its in vitro effect on cement release properties and on human osteoprogenitor cell activities in contact with these cements. Physico-chemical characterizations were performed in order to determine the effects of strontium and the way it is introduced into the self-setting paste on hardened cement composition and properties. Finally, in vitro assays were performed to evaluate the effect of strontium-loaded cements on the proliferation and differentiation of human osteoprogenitor cells isolated from bone marrow stromal cells to emphasize the link between strontium release and the activity of bone forming cells.
MATERIALS AND METHODS

Reactive powder synthesis
The solid phase of the reference cement (without strontium) was composed of dicalcium phosphate dihydrate (DCPD) and CaCO 3 -vaterite (V), which were synthesized by precipitation at ambient temperature as previously described in detail. 27 Commercial strontium salts with different solubilities were purchased and used without further purification: SrCO 3 (Alfa Aesar V R ) was introduced in the solid phase and SrCl 2 .6H 2 O (Normapur V R ) in the liquid phase.
Paste preparation
As previously described in detail, the reference cement paste was manually prepared by mixing equal weight of vaterite and DCPD (1:1) with deionized water as the liquid phase. 27 The liquid to solid ratio (L/S) was equal to 0.5 (w/w).
Strontium was introduced into the cement either in the solid phase or in the liquid phase by means of strontium salts with different solubilities. Considering the properties of different strontium salts (chloride, nitrate, carbonate, etc.), commercially available SrCO 3 and SrCl 2 .6H 2 O were chosen to introduce Sr in the cement via the solid or via the liquid phase, respectively. In the case of SrCO 3 , carbonate ions were already present in the reference cement; consequently no other type of counter-ions would therefore be introduced in the cement. In addition, SrCO 3 has a solubility close to that of vaterite CaCO 3 which is already present in the cement; consequently SrCO 3 should be resorbable. SrCl 2 .6H 2 O salt was selected to introduce Sr in the cement via the liquid phase because of its high solubility and of the non-toxicity of counter-ions (Cl À ). Table I On the one hand, varying amounts of the less soluble salt, strontium carbonate (SrCO 3 ), were added to the solid phase including the same weight ratio of vaterite and DCPD (1:1) and thus led to various weight percentages (wt%) of SrCO 3 in the solid phase (5, 10, 15, or 20 wt%) and consequently to various wt% of Sr in the paste (2, 4, 6, or 8%, respectively). These cements were prepared with the same L/S ratio (0.5) as the reference paste (Table I) .
On the other hand, varying amounts of the more soluble salt, i.e., strontium chloride (SrCl 2 .6H 2 O), were dissolved in deionized water resulting in solutions with different concentrations in Sr 2þ ions and viscosities. The reference solid phase (DCPD þ V; 1:1) was then mixed with the as-prepared Sr solutions, leading to pastes that were prepared with the same L/S ratio (0.5) as the reference paste, containing various wt% of Sr (2, 4, 4.7, or 6 wt%) ( Table I ). Note that because of the solubility of SrCl 2 .6H 2 O in water, the maximum amount of Sr dissolved in the liquid phase and consequently included in the paste via this route was 6 wt% (compared to 8 wt% for the SrS cements). In all cases (reference or Sr-loaded cements), the paste was then left to set in a sealed container at 37 C and in an atmosphere saturated with water (%100% humidity). The hardened and dried cements were analyzed after maturation for four days at 37 C.
Powder and cement characterization All of the synthesized and commercial powders and the reference and Sr-loaded hardened cements were characterized by transmission Fourier transformed infrared (FTIR) spectroscopy with KBr pellets (Nicolet 5700 spectrometer, ThermoElectron), X-ray diffraction (XRD) (Inel CPS 120 diffractometer) using a Co anticathode (k ¼ 1.78897 Å) and scanning electron microscopy (SEM) (LEO 435 VP microscope; silver plating of sample before observation).
A preliminary Rietveld refinement analysis was performed on SrL cement XRD patterns. The MAUD program was used to refine the lattice parameters. 29 Space groups, cell parameters, and atomic positions of the different phases: vaterite and Sr-substituted hydroxyapatite, were introduced as initial structural models. 30, 31 The Caglioti function (half the width of the diffraction peaks as a function of 2y) was evaluated using a LaB6 powder (NIST-660B). The peak shapes were fitted by using a pseudo-Voigt function. The errors on the calculated unit cell parameters were 6.10 À3 Å for a and 3.10 À3 Å for c. 3 at physiological pH 7.4. The bowls were sealed and kept at a temperature of 37 C. Samples of 10 mL of the working solution (buffer solution in which the cement had begun to dissolve) were removed at different times and replaced by the same volume of fresh buffer solution to keep the volume of the release medium constant throughout the experiment. The dilution factors that followed from this adjustment were considered in all calculations.
In vitro release tests
Even if no particles or very few particles were released from the cements, the solutions removed were then filtered using 0.2 lm cellulose membrane filters to remove potential particles that could dissolve during storage of the solution before analysis and which could interfere during the analysis. The filtrates were stored at þ4 C before analysis. This experiment was performed in triplicate for each type of cement tested.
Characterization of the working solution. Concentrations of Ca and Sr in the working solution removed at different times were determined using atomic absorption spectroscopy (AAS) (PerkinElmer Flamme AAS, AAnalyst 400). Standard solutions from 0 to 5 ppm (linearity range for both Ca and Sr) were prepared using the same buffer solution as the one used for the release tests. Except for the samples removed at the earliest times (lowest calcium and strontium concentrations), the samples were diluted before measurements with the same buffer solution to reach the 0-5 ppm range.
Characterization of cements after release test. After three weeks in the buffer solution, the cements that had been immersed were removed from the solution and dried in an oven at 37 C. For each type of cement, two samples were manually ground and replaced in their respective working solution for an additional 24 h to determine the maximum amounts of calcium and strontium that could possibly be dissolved under these experimental conditions. The third sample was characterized by the analytical techniques indicated in the Powder and Cement Characterization section. Raman micro-spectroscopy (Labram HR 800 Horiba Jobin Yvon micro-spectrometer) and porosimetry analyses were carried also out. The total porosity of the cements was determined using a mercury intrusion porosimeter (Autopore IV 9400 Micromeritics V R Instruments Inc.) with a 5 cm 3 solid penetrometer. Energy dispersive X-ray (EDX) elemental mapping was performed using a scanning electron microscope LEO 435 VP and an IMIX-PGT analyser (Princeton Gamma Tech) equipped with a Ge detector.
In vitro cell culture study Cell viability, proliferation, and differentiation were evaluated in vitro for the three types of cement in direct contact with human osteoprogenitor cells: the reference cement, the SrCO 3 -loaded cement (8% SrS), and the SrCl 2 -loaded cement (4.7% SrL). Cement disks (1 cm diameter and 4 mm thickness) were prepared and polished until smooth after the cement had set to give an even surface. The cement disks were then sterilized by c-ray irradiation (25 KGy) before the cell culture assays.
Cell culture. Osteoprogenitor cells were isolated from human bone marrow stromal cells (HBMSCs) according to the method of Vilamitjana-Amédée et al. with some modifications. 32, 33 Briefly, human bone marrow was obtained by aspiration from the iliac crest of healthy donors (aged 20-50 years) undergoing hip prosthesis surgery. The cells were separated into a single suspension by sequentially passing the suspension through syringes fitted with 16, 18, or 21 gauge needles. After centrifugation for 15 min at 800 g, the pellet was resuspended in Iscove Modified Dulbecco's Medium (IMDM, from Gibco, InVitrogen, Carlsbad, CA) supplemented with 10% (v/v) foetal calf serum (FCS, from Gibco) and 10 À8 M dexamethasone (Sigma, St. Louis, MO) in order to drive the cells to the osteogenic phenotype. The cells were then placed into 75 cm 2 cell culture flasks (Nalgene Nunc, Rochester, NY), at a density of 5 Â 10 5 cells/cm 2 and incubated in a humidified atmosphere of 95% air 5% CO 2 at 37 C. Five days later, the medium was removed, replaced twice with the complete medium supplemented with 10 À8 M dexamethasone, and then every 3 days replaced with IMDM containing 10% FCS (v/v). Subculturing was performed using 0.2% (w/v) trypsin and 5 mM ethylenediaminetetraacetic acid (EDTA). Cell differentiation was followed at different times during cell culture by measuring alkaline phosphatase activity and osteocalcin synthesis, as previously described. 32 Cell viability and proliferation assays. Cell viability and mortality were determined using a LIVE/DEAD viability/ cytotoxicity kit, according to the manufacturer's protocol (Molecular Probes). Cell proliferation assays, quantified by MTT analysis were performed as described by Mosmann. 34 All assays were performed using at least six replicates for each condition tested. Cell proliferation on tissue culture polystyrene (TCPS) in plastic culture dishes was used as the positive control. In order to prevent cell attachment to the plastic dishes, an agarose layer (2% (v/v) in 0.1 M phosphate buffered saline (PBS at pH 7.4) was deposited in the wells, and the cement discs were placed on this layer and incubated overnight at 37 C in IMDM. Thereafter, the discs were seeded with 20 Â 10 3 cells per cm 2 in IMDM supplemented with 10% (v/v) FCS. The cultures were incubated at 37 C in a humidified atmosphere. The culture medium was renewed every 3 days. Cell growth was quantified after 1, 3, 9, and 15 days by measuring the metabolic activity of the cells by the MTT assay. This assay is based on the observation that a mitochondrial enzyme of viable cells has the ability to metabolize a water-soluble tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide into an insoluble formazan salt. Briefly, 3 h after incubation of the MTT solution at 37 C, the solution was removed, the insoluble formazan crystals that had formed were dissolved in dimethylsulphoxide and 100 lL was aspirated and poured into another 96-well plate for absorbance measurements at 540 nm. The intensity of the staining obtained was directly proportional to the cell density (see AFNOR-NF EN 30993-5 and ISO 10993-5 standards). The cements were removed from the milieu after 15 days of culture, dried at 37 C and then characterized by the analytical techniques indicated in the Powder and Cement Characterization section.
The culture media that were removed after incubation, and one and nine days of cell culture were filtered through cellulose membranes and the calcium and strontium concentrations were determined by absorption spectroscopy (PerkinElmer SAA Flamme, AAnalyst 400, see the Characterization of the Working Solution section).
Cell morphology and surface characterization. After 15 days of culture, SEM observations were carried out in order to examine cell morphology on the culture discs. The samples were fixed by 15 min immersion in a 2% (v/v) glutaraldehyde in 0.15 M cacodylate buffer (pH 7.3). The samples were washed with 0.15 M cacodylate buffer for 10 min, then dehydrated by successive immersions in ethanol solutions (from 25 to 100%), and then finally dried by the CO 2 critical point technique and Au-sputtered before observation. SEM analyses were carried out at 15 and 20 keV for 60 s using a Hitachi (Tokyo, Japan) S-2500 scanning electron microscope.
Quantitative real time polymerase chain reaction (Q-PCR). Total RNA was prepared from the cells using a Machery-Nagel Nucleospin RNA extract II kit, according to the manufacturer's instructions. Adequacy of the RNA quality was assessed photometrically and by agarose gel electrophoresis.
A 1 lg weight of RNA was used as a template for singlestrand cDNA synthesis using the Superscript system (Fisher Scientific) in a final volume of 20 lL containing 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 2.5 mM MgCl 2 , 0.1 mg/mL BSA, 10 mM DTT, 0.3 mM of each of dATP, dCTP, dGTP, and dTTP, 0.5 lg oligo(dT)12-18 used as a primer and 50 U of reverse transcriptase. After incubation at 42 C for 50 min, the reaction was stopped at 70 C over a period of 15 min. The data were analyzed with the iCycler iQ software and compared using the DDCt method. Each Q-PCR was performed in triplicate for PCR yield validation. The data were normalized to PO mRNA expression for each condition. We have chosen P0 as the reference or housekeeping gene that encodes for a ribosomal protein and which is not influenced by the experimental conditions. The results were thereafter normalized to the expression of the corresponding gene, expressed by the cells cultured on the plastic culture dishes (that represent one as relative value). Statistical significance was calculated by Student's t-test.
RESULTS
Sr-loaded cement characterization
All compositions of the Sr-loaded pastes that were tested (Table I) led to hardened cements. The set reference cement was composed of vaterite and nanocrystalline apatite which was shown to be carbonated in a previous paper. 27 X-ray diffraction analysis [ Figure 1(a) ] of the set cements showed that when SrCO 3 was included in the solid phase it remained in the final cement, thus the composition was comprised of carbonated apatite, vaterite, and strontianite (SrCO 3 ). The relative intensity of the diffraction peaks of strontianite clearly increased as the initial load of SrCO 3 increased indicating that this compound did not have a significant part in the setting reaction. When strontium chloride was introduced into the paste via the liquid phase, no additional phase was detected compared to the reference cement [ Figure 1(b) ]. The preliminary Rietveld refinement analysis of cement XRD diagrams enabled the determination of apatite cell parameters as a function of Sr-loading in the liquid phase and thus in the cement paste; the evolution of these parameters can be observed in Figure 2 and compared with the Vegard's law, as described by Leroux et al., for partly substituted apatite Ca 10-x Sr x (PO 4 ) 6 (OH) 2 .
35 Considering the study of Leroux et 
The total porosity of the different Sr-loaded cements is reported in Table II . The introduction of strontium into the cement formulation led to a decrease of about 10% of the total porosity compared with the total porosity of the reference cement. Upon examining the pore size distribution (Figure 3) for the different Sr-loaded cements that were prepared, it could be seen that when strontium was introduced into the cement formulation, either in the solid or liquid phase, the size of the bigger pores increased (for example, from 4 to 26 lm for 8% SrS cement). It is important to note that for all of the cements the nanosized pores played a prominent role in the total porosity of the cement (in the case of 8% SrS cement with a total porosity of 49%: 45% by the pores of an average size of 8 and 20 nm compared to a contribution of 4% by pores of an average size of 25 lm).
Strontium and calcium release in vitro
The concentrations of calcium and strontium ions released from the different cements tested in the working solution are plotted against time in Figure 4 . Regarding calcium release [ Figure 4 (a)], all of the cement types showed the same trend: even though the SrL cements showed a higher release rate, calcium was continuously released from the cements, with a faster rate of release during the first 50 h and slower afterward. The cumulated Ca concentration in the working solution after 3 weeks reached 0.06 g/L for the reference cement, 0.05 g/L for 8% SrS, and 0.08 g/L for the 4.7% SrL cement (values normalized per gram of cement that was initially introduced into the working solution). Regarding strontium release [ Figure 4 (b)], both Sr-loaded cements showed different trends. Although it contained less strontium, the amount of strontium released from the SrL cement was higher than that from the SrS cement during the first 50 h. Then the rate of strontium release slowed down and reached similar or lower rates than SrS cement after one week in solution. After 3 weeks of being tested in the release solution, the cumulated Sr concentration in solution reached 0.021 g/L for 8% SrS cement and 0.016 g/L for SrL cement (values normalized per gram of cement that was initially introduced into the working solution).
In order to determine the mechanism of Sr release and the dissolution of the cements, it was important to characterize the cements after the in vitro tests in the presence or absence of cells: X-ray diffraction analysis provided the global composition of the cement, whereas Raman microspectroscopy provided the local one. [ Figure 5 (a,c), respectively]: vaterite remained in the three types of cements either after three weeks in buffered solution or after two weeks in contact with culture medium and cells. However, a significant difference can be clearly observed for the XRD patterns of the cement powders replaced in the working solution for an additional 24 h [Figure 5(b) ]: the diffraction peaks characteristic of vaterite are no longer visible on the XRD pattern of the SrS cement and they are of a very low intensity for the reference and SrL cements. This indicates that the vaterite, which remained in the cement blocks after 3 weeks, dissolved within 24 h when the blocks were ground into powders. The resulting SrL cement consisted of a poorly crystallized apatite showing broader and less well resolved peaks than SrS or the reference cement. In the case of the SrS cement, it can be noted that nanocrystalline apatite co-existed with the well-crystallized SrCO 3 , which remained in the cement after the release test regardless of the form of the cement (block or powder). This result indicated that strontianite (SrCO 3 ) was stable in the Tris buffer solution at pH 7.4 and 37 C. However, in order to further investigate the composition of these cements after the 3-week release test, we performed elemental mapping by EDX and Raman micro-spectroscopy analyses on a cross-section of the cement cylinders.
Elemental mapping of the three types of cement was performed for calcium, phosphorus, and strontium ( Figure 6 ). In particular, the phosphorus maps revealed heterogeneity in the composition with a brighter peripheral layer indicating a relatively higher concentration of phosphorus than in the center of the cement. However, this P-rich peripheral layer was less marked for the SrL cement. Upon examination of the strontium maps, it could be seen that this element was homogeneously distributed within the SrL cement, supporting the hypothesis of the incorporation of Sr in the apatite lattice, whereas for the SrS cement some brighter spots indicated the presence of SrCO 3 agglomerates that were not homogeneously distributed. In addition a brighter peripheral layer can be distinguished for the SrL cement indicating a relatively higher concentration in strontium than in the center of the cement probably due to the preferential dissolution of vaterite in this zone thus mainly consisting of strontium-substituted apatite. Figure 7 shows the spectra of the SrS cement after 3 weeks of in vitro release test compared with spectra of the reference compounds (vaterite, SrCO 3 , and the carbonated apatite analogous to bone mineral). The spectrum of the edge of the cement cylinder mainly shows the characteristic band of the phosphate groups in carbonated apatite (960 cm À1 ); a low intensity band at 1070 cm À1 indicating the presence of SrCO 3 could also be distinguished. Note that this band was superimposed on the band of very low intensity at 1070 cm À1 , characteristic of phosphate groups in carbonated apatite. This spectrum was completely different from the one obtained when the center of the cement was analyzed, where intense bands characteristic of carbonate groups in vaterite (1075-1090 cm
À1
) and SrCO 3 (1070 cm À1 ) were seen, along with a less intense band characteristic of phosphate groups in carbonated apatite. This Raman spectroscopy data confirmed the EDX spectroscopic data ( Figure 6 ).
Upon comparing the total porosity of the cements before and after the release test (Table II) , it can be seen that it was significantly higher after the in vitro test: this increase was more important for the Sr-loaded cements.
Examination of the pore size distribution after the in vitro release test suggested the formation of a secondary porosity during cement degradation in vitro [ Figure 3(b) ]. The pore size distribution around 10 nm, which was bimodal before the test for the reference and SrS cements, became monomodal and broader toward the higher pore sizes; pores of about 100 nm were created. In addition, after the release test, the SrL cements presented a secondary pore size distribution (around 8 nm) of smaller pore sizes than before the test. A broadening of the pore size distribution toward higher pore sizes was noted for the SrS and SrL cements. This result could have been due to degradation of the cements, and particularly to the dissolution of vaterite CaCO 3 and SrCO 3 .
In vitro cell culture study Results were obtained from three separate experiments that used human osteoprogenitor cell cultures arising from three different donors of bone marrow. Figure 8 shows that the cells seeded on Sr-loaded cements exhibited the same profile of proliferation from day 1 to day 9 of culture as for the reference cement. However, the rate of proliferation remained significantly lower on these materials than on the plastic culture dishes, especially at day 9 and day 15. After 15 days of culture, it was noted that the human osteoprogenitor cells showed a more significant proliferation on SrS cement than on either the reference or the SrL cements.
Live/dead assays performed on the three types of cements [ Figure 9 (d-f)] mainly revealed living cells on these three surfaces. This analysis was corroborated by a SEM examination [ Figure 9 (a-c)], which showed cells that were well spread out with numerous filopodia, regardless of the substrate (reference, SrL, or SrS cements).
Q-PCR was performed to quantify the mRNA levels of the early bone-specific marker (alkaline phosphatase) and the later bone-specific marker (osteocalcin) after 15 days of culturing the human osteoprogenitor cells on the three cement types (reference, SrL and SrS) and on the plastic culture dishes as control ( Figure 10 ). The expression of ALP mRNA levels in cells cultured on these three cements did not differ, regardless of whether the cement was loaded with strontium or not. The same result was obtained for the late osteoblastic marker osteocalcin, which was not significantly regulated by the presence of strontium within the cements. However, the expression of these two bone markers was overexpressed in cells cultured on the three types of cements in comparison with the control surfaces (plastic culture dishes), regardless of the presence of strontium within the cements (Figure 10 ).
The concentrations of strontium and calcium released into the culture medium after the overnight incubation of the cements, after 1 and 9 days of cell culture, are presented in Figure 11 . A burst of release of strontium and calcium occurred during incubation and on the first day of cell culture for the 4.7% SrL cement, whereas their release was moderate at 9 days of cell culture. The calcium release rate for 8% SrS cement was quite similar to that of the reference cement [ Figure 11(a) ]. The calcium and strontium release rates for the 8% SrS cement were very low compared with those of the 4.7% SrL cement, indicating a different bioavailability of strontium and cement biodegradation properties depending on the Sr-loading route chosen for the cement.
DISCUSSION
Sr-loaded cement compositions and properties Several authors have investigated various routes for introducing strontium into apatite or brushite bone cements and a commercial cement formulation includes strontium carbonate. 8, 23, 26, [36] [37] [38] [39] In all cases, strontium was introduced in the solid phase. In the present study, we investigated the introduction of strontium in solid and liquid phases and the feasibility of both types of self-setting pastes was demonstrated. Interestingly, the two different routes used to introduce strontium into the cement led to two different compositions of cements: when SrCO 3 was included in the solid phase it remained in the final cement composition, whereas when SrCl 2 was dissolved in the liquid phase Sr 2þ ions were readily available in the paste and could be incorporated into the apatite phase during the setting reaction by substituting Ca 2þ ions and consequently no additional phase was detected compared with the reference cement. Variations in a and c parameters of the apatite lattice were also reported by Wang et al. as a function of the Sr/(CaþSr) molar ratio when two routes of introduction of strontium in the solid phase of amorphous calcium phosphate and DCPD cement were investigated. 39 The variation they reported for the c parameter was higher (higher slope) than shown in Figure 2 of the present study and was thus closer to that reported by Leroux et al. 35 The lower increase of c parameter observed in the present study (Figure 2 ) could be due to the concomitant substitution by strontium and chloride (from SrCl 2 salt dissolved in the liquid phase) in the apatite. Indeed the effect of Sr on the crystallographic parameters of apatite is rather large, especially on the c dimension, whereas chlorine incorporation would have an opposite effect on this dimension. In addition the 00l lines are rather narrow due to elongated shape of the apatite crystals and the variation reported is significant. These simple considerations support the data obtained by our preliminary Rietveldt refinement analysis, considering also that the atomic diffusion coefficient of Sr is much larger than that of Ca and that even small amounts of Sr incorporation are quite observable on XRD data as shown by several authors. 11, 39, 41 However, it is important to note that in the present study, the possibility of having concomitant substitution of calcium by strontium and hydroxide by chloride, the coexistence of various degrees of substitution into the apatite formed in the SrL cement and its low crystallinity did not allow us to obtain reliable quantitative information on the amount of strontium incorporated in the apatite lattice. Considering the work of O'Donnell et al. Raman spectroscopy can also be useful to identify and quantify Sr substitution in hydroxyapatite: the position of the m 1 PO 4 band in hydroxyapatite (961 cm À1 ) decreased linearly for Sr-substituted hydroxyapatites and the full width at half maximum of this band can well correlated and increased linearly with increasing crystallite size calculated by XRD analysis. 40 These various cement compositions should lead to different behaviors of the cement in solution considering the solubility of hydroxyapatite and of Sr-substituted hydroxyapatite. Indeed, the different crystallization and dissolution properties of such apatites should determine the setting of the cement (formation of apatite) and its biodegradation and release properties. Christoffersen et al. reported the inhibitory role of strontium on the rates of dissolution and crystal growth of hydroxyapatite and 10% Sr-containing hydroxyapatite; the latter was less affected than the former. 41 Our results showed that partially substituted Srhydroxyapatite was formed in SrL cements and that early high rates of released calcium and strontium were detected when the SrL cement was tested in vitro in both the presence and absence of osteoprogenitor cells, whereas the SrS cement, which was mainly composed of hydroxyapatite, showed a relatively moderate release of ions. It is now interesting to discuss the release and dissolution properties of these cements.
Release and dissolution properties of strontium-loaded cements Several studies reported associations between calcium phosphate bone cements and drugs (antibiotics, bisphosphonates, and growth factors, for example) as in situ drug release systems. [42] [43] [44] [45] [46] However, very few studies investigated strontium release from Sr-loaded cements. 13, 20 Alkhraisat et al. investigated strontium release at 37 C in pure water in dynamic conditions (water refreshed daily) for brushite cements prepared with a solid phase including strontiumsubstituted tricalcium phosphate. 13 In the present work, we studied strontium release in a buffered solution at pH 7.4 and 37
C over a period of 3 weeks. For both types of Sr-loaded cements, we observed a sustained release of strontium for 3 weeks in both the presence and absence of osteoprogenitor cells, including an initial burst of release of Ca and Sr during the first 48 h (Figures 4 and 11) . After an initial period (24 h for the SrS cement), the ratio of the Ca/Sr released then stabilized at around 2.5 and remained constant throughout the rest of the experiment. Note that the Ca/Sr ratio in the cement paste was 2.1 and that the Ca/Sr ratio released was therefore higher. We can hypothesize that the CaCO 3 -vaterite, which remained in the cement after the setting reaction (Figure 1) , and which is the more soluble phase, dissolved first, explaining the high Ca/Sr ratio during the first couple of days. Then, SrCO 3 also began to dissolve, which explains the decrease in the Ca/Sr ratio. The EDX elemental mapping revealed a relative increase in phosphorus in the peripheral layer of all the cement blocks, which confirms the hypothesis of the early dissolution of vaterite CaCO 3 and consequently a relative enrichment of the less soluble apatite in the peripheral layer ( Figure 6 ). This less soluble peripheral layer could constitute a barrier that would slow down the dissolution of vaterite from the core of the cement. However, this effect could be partially compensated for by the formation of a secondary porosity that could facilitate the diffusion process. The Raman micro-spectroscopy analysis performed on two regions of the SrS cement cylinder (edge and center, Figure 6 ) after the release test confirmed the dissolution of vaterite on the edge, suggesting that the vaterite dissolution process was limited by diffusion during the in vitro test. In addition, the centripetal dissolution of vaterite was confirmed by comparing the results of the X-ray diffraction analysis on blocks and powders (ground cement blocks) removed after the in vitro release tests [ Figure 5(a,b) ]. As diffusion is a less limiting process for cement dissolution when in the form of a powder compared to a block, vaterite was almost completely dissolved within 24 h when the ground cement was tested in the release solution [ Figure 5(b) ].
In the case of 4.7% SrL cement, the release of calcium and strontium was very high during incubation and the first day of cell culture ( Figure 11 ), in correlation with the results of the in vitro release test (Figure 4 ). This initial burst of release could have slightly reduced cell proliferation in comparison with the SrS and reference cements (Figure 8) .
However, in all cases, the daily doses of strontium released per gram of cement (for example, for the 4.7% SrL cement: 8 mg during the first day of the release test and 0.5 mg during the third week) were lower than the therapeutic doses used for oral administration and in the same order of magnitude as the in situ dose proposed by Alkhraisat (i.e., between 12 and 30 mg Sr/L). 3, 13 However, it is difficult to compare these two therapeutic routes (in situ or oral administration) in terms of Sr level distribution locally around the cement/bone defect and generally in circulating blood.
Contrary to what was observed for the SrS cement, the ratio of the Ca/Sr released rapidly stabilized at around 4.6 for the SrL cement, which exactly corresponded with the initial Ca/Sr molar ratio (in the cement paste). This result may indicate that the release mechanisms of SrS and SrL cements are different. In order to investigate this point further, the release kinetics shown in Figure 4 (a,b) were modeled. If release/dissolution kinetics fit the Higuchi model, this indicates that diffusion is the main mechanism involved in the release of the drug. 47 The Higuchi model links the percentage of the drug released, Q, to the time, t, and k, a rate constant, as defined in the following equation: Figure 12 shows that the evolution of Q as a function of t 1/2 for the release of strontium from the 8% SrS and 4.7% SrL cements was linear for the SrS cement and non-linear for the SrL cement. These results suggest that for the SrS cement, strontium was released by diffusion through the porous network created by the water inside the cement, whereas such a mechanism was not involved or not predominant for the SrL cement. In this latter case, the release of strontium may have been limited by the dissolution of Sr-substituted apatite or its degradation when in the presence of cells. This hypothesis was supported by Raman micro-spectroscopy and EDX elemental mapping analyses (Figures 6 and 7) . Moreover, the results obtained with the mercury porosimeter highlighted the creation of a secondary porous network for the SrS and SrL cements, which could have been due to water diffusion into the cement.
Another parameter that could have been involved in the higher release and dissolution rates of SrL cements during the first week is related to the higher initial porosity of these cements. According to the work of Cazalbou et al., the surface of nanocrystalline biomimetic apatite which is formed during cement setting can undergo fast Ca-Sr cationic exchanges depending on the composition of the solution, which could have contributed to the initial burst of release of Sr that we observed in vitro. 1, 48 Finally, another parameter involved in the release process was the solubility of the apatite formed during the cement setting reaction. The greater release of Sr and Ca from the SrL cement is in agreement with the increase in solubility with the increasing content of Sr 2þ in the apatite crystal. 41, 49 Interestingly, these results suggest that it is possible to control the release of Sr 2þ and the biodegradation of the cement by the method used to introduce strontium into the cement paste.
Previous studies performed on Sr-loaded biomaterials showed that the proliferation and differentiation of cells is Sr-dose dependent. 9, 14, 25 Therefore, a possible correlation between the release/dissolution properties on the proliferation and differentiation of osteoprogenitor cells is discussed in the next paragraph.
Effect of Sr-loaded cements on osteoblast cell activity Several recent works investigated the effect of strontium from Sr-doped mineral cements, coatings, and ceramics on cell proliferation and differentiation. [8] [9] [10] [11] [12] [13] [14] 24, 25, 37 Alkhraisat et al. showed that cytocompatibility of Sr-containing brushite cements was as good as that of reference brushite cements (without Sr) via culturing the human osteoblast cell line hFOB1. 19 . 13 In addition, two cell lines were tested on Sr-containing brushite cements by Pina et al.: their results showed the stimulation of pre-osteoblastic proliferation and osteoblastic maturation of MC3T3-E1 cells and non-cytotoxicity toward human osteosarcomaderived MG63 cells. 8 In our study, regardless of the composition of cement tested, the human bone marrow stromal cells showed similar proliferation profiles up to 9 days of culture. After this, cell proliferation was 50% higher on the SrS cement compared to reference and SrL cements (Figure 8 ). The correlation between the results of cell proliferation ( Figure 8 ) and Sr release in vitro in the absence (Figure 4 ) and presence of cells ( Figure 11 ) suggested that the early released dose of strontium had a determinant role on cell proliferation. Braux and coworkers have recently determined the optimal range of SrCl 2 concentration in solution (between 10 À5 and 10 À4 M) to enhance primary bone cell proliferation. 9 This range of strontium concentrations is lower compared with the strontium concentrations measured in the culture medium during cell culture on the three types of cement ( Figure 11 ). The promoter role of the three types of cement was confirmed by examining the high level of differentiation in gene expression in comparison with the plastic culture dishes. However, it appeared that strontium did not stimulate the expression of the early bone marker (alkaline phosphatase), or the late osteoblastic marker (osteocalcin). It is important to note that titration of the Sr and Ca released in the cell culture medium as a function of time revealed that the incubation of Sr-loaded cements in IMDM medium for one night before cell seeding avoided contact of the cells with the highest doses of early released Sr (Figure 11 ).
These results show the beneficial effects of low doses of strontium released (<8 mg/day/g of cement) on cell proliferation and differentiation that were closely related to the sustained release of strontium from Sr-loaded vaterite-DCPD cements.
In addition, we used human bone marrow stromal cells that were driven to osteogenic differentiation by dexamethasone (inductive factor), and then cultured in IMDM medium. The other papers published in the literature used different cell lines including transformed cell lines cultured in basic medium such as aMEM. The sensitivity of these differentiated cells could be different depending on the length of culture and the release of strontium within the medium in contact with these Sr-loaded cements.
CONCLUSION
Strontium is a biocompatible and bioactive element that can be introduced either as SrCO 3 in the solid phase or as SrCl 2 Á 6H 2 O dissolved in the liquid phase for the preparation of original vaterite CaCO 3 -DCPD cement compositions. We showed that the various cement compositions obtained led to different release and dissolution behaviors, in agreement with the solubility of the constituting phases of the set cement (vaterite and apatite or strontium-substituted apatites). The in vitro release test at 37 C and the cell culture studies demonstrated that there was an initial burst of release of strontium in the medium, (highest for the SrL cement) followed by a sustained release over 3 weeks, which did not have a deleterious effect on human osteoprogenitor cell activity. The expression of an early bone marker (alkaline phosphatase) and a later bone marker (osteocalcin), which levels were overexpressed after 15 days of cell culture, was not significantly affected by the presence of strontium either within the cements or released into the medium. However, the enhanced proliferation of human osteoprogenitor cells was observed after 15 days of culture in contact with the SrS cement, which appeared to be the most promising bioactive cement composition. Interestingly, this study showed that the sustained release of Sr 2þ , the cement biodegradation rate and the biological activity could be optimized by controlling the route of introduction of strontium into the cement paste.
